Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

2010 Medicare inpatient rule

This article was originally published in The Gray Sheet

Executive Summary

In its final rule released July 31, CMS pulled back on an earlier proposal to negatively offset the 2010 hospital inpatient payment update by 1.9%. The proposed offset was intended to correct for what CMS says were Medicare overpayments in 2008, but the agency was convinced that more data was needed to support the change. Device analysts had been concerned that such a cut would have increased pricing pressures on some devices (1"The Gray Sheet" May 11, 2009). In 2010, acute care hospitals will receive a positive payment update of 2.1%

You may also be interested in...



2010 Device DRGs Stable, But Longer-Term Hospital Cuts Could Make A Mark

Medical device manufacturers are not expected to take a direct hit from Medicare inpatient hospital payment cuts next year, but possible cuts through 2012 could start to add pressure on manufacturers

Cosmetic And Personal Care Trademark Review 24 November, 2020

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

CBD Health Benefits More Attractive To Women? FDA Prioritizes Research Into Utero Effects

Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA  neuroscientist Andrew Shen.

Topics

UsernamePublicRestriction

Register

LL1134531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel